(NUWE) – FDA
-
Nuwellis (NUWE) Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
-
Nuwellis (NUWE) Announces Peer Reviewed Data Demonstrating 71% Survival with Kidney Replacement Therapy
-
-
Back to NUWE Stock Lookup